dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Aterido Ballonga, Adria |
dc.contributor.author | Guerra, Iván |
dc.contributor.author | Cabriada, Jose Luis |
dc.contributor.author | Marsal Barril, Sara |
dc.contributor.author | Julia Cano, Antonio |
dc.contributor.author | Chaparro, María |
dc.contributor.author | Bujanda, Luis |
dc.contributor.author | Iborra, Marisa |
dc.date.accessioned | 2020-07-29T12:23:29Z |
dc.date.available | 2020-07-29T12:23:29Z |
dc.date.issued | 2019-09-25 |
dc.identifier.citation | Chaparro M, Aterido A, Guerra I, Iborra M, Cabriada JL, Bujanda L, et al. Functional rare variants influence the clinical response to anti-TNF therapy in Crohn’s disease. Therap Adv Gastroenterol. 2019 Sep 25;12:175628481986784. |
dc.identifier.issn | 1756-2848 |
dc.identifier.uri | https://hdl.handle.net/11351/5120 |
dc.description | Adalimumab; Malaltia de Crohn; Infliximab |
dc.description.sponsorship | The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was funded by grants from the "Instituto de Salud Carlos III" (FIS.12/02557 and PI13/00041). |
dc.language.iso | eng |
dc.publisher | SAGE Publications |
dc.relation.ispartofseries | Therapeutic Advances in Gastroenterology;12 |
dc.rights | Attribution-NonCommercial 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ |
dc.source | Scientia |
dc.subject | Crohn, Malaltia de |
dc.subject | Factor de necrosi tumoral |
dc.subject | Genoma humà - Mapatge |
dc.subject.mesh | Crohn Disease |
dc.subject.mesh | Receptors, Tumor Necrosis Factor |
dc.subject.mesh | Genome-Wide Association Study |
dc.title | Functional rare variants influence the clinical response to anti-TNF therapy in Crohn’s disease |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1177/1756284819867848 |
dc.subject.decs | enfermedad de Crohn |
dc.subject.decs | receptores de factores de necrosis tumoral |
dc.subject.decs | estudio de asociación genómica completa |
dc.relation.publishversion | https://journals.sagepub.com/doi/10.1177/1756284819867848 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.authoraffiliation | [Chaparro M] Gastroenterology Unit. Hospital Universitario de La Princesa, Madrid, Spain. Instituto de Investigación Sanitaria Princesa (IIS-IP), Madrid, Spain. Universidad Autónoma de Madrid, Madrid, Spain. [Aterido A, Marsal S, Julia A] Grup de Recerca en Reumatologia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Guerra I] Gastroenterology Unit, Hospital Universitario de Fuenlabrada, Madrid, Spain. Instituto de Investigación de Hospital La Paz (IdiPaz), Madrid, Spain. [Iborra M] Gastroenterology Unit, Hospital Universitario de La Fe, Valencia, Spain. [Cabriada JL] Gastroenterology Unit, Hospital Universitario de Galdakano, Vizcaya, Spain. [Bujanda L] Gastroenterology Unit, Hospital Universitario de Donostia, San Sebastián, Spain. Instituto Biodonostia, San Sebastián, Spain. UPV/EHU, Bilbao, Spain. Ikerbasque, Bilbao, Spain |
dc.identifier.pmid | 31598133 |
dc.identifier.wos | 000487943200001 |
dc.relation.projectid | info:eu-repo/grantAgreement/ES/PE2013-2016/PI13%2F00041 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |